Trial Profile
Retrospective study to investigate the safety and efficacy of tolvaptan in treating chronic kidney disease in patients with diabetic nephropathy with heart failure
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Dec 2015
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Diabetic nephropathies; Renal failure
- Focus Adverse reactions; Therapeutic Use
- 04 Dec 2015 New trial record